
Global Empty Capsules Market Size Study, by Type (Gelatin, Non-Gelatin), Functionality (Immediate-Release, Sustained-Release, Delayed-Release), Therapeutic Application (Antibiotic, Dietary, Antacid, CVD), and Regional Forecasts 2024-2034
Description
The Global Empty Capsules Market is valued at approximately USD 3.1 billion in 2024 and is anticipated to grow at a (CAGR) of 5.9% over the forecast period 2024-2034. Empty capsules, primarily composed of gelatin or plant-based materials, have become indispensable in the pharmaceutical and nutraceutical industries. These capsules provide a protective shell for medications and dietary supplements, facilitating controlled release and enhanced bioavailability of active ingredients. The rise of patient-centric healthcare and personalized medicine is driving innovation in capsule design, with manufacturers exploring novel materials and functional coatings. Empty capsules cater to diverse therapeutic applications, ranging from antibiotics to cardiovascular treatments, solidifying their pivotal role in drug delivery systems.
The expanding pharmaceutical and nutraceutical sectors, coupled with growing consumer inclination toward dietary supplements, are the primary catalysts for market growth. For instance, the surge in demand for plant-based alternatives has prompted the development of non-gelatin capsules such as Hydroxypropyl Methylcellulose (HPMC). Advances in capsule manufacturing technology enable precision customization for specific drug delivery needs, such as immediate-release or delayed-release formulations. However, the market faces challenges, including fluctuating raw material prices and stringent regulatory compliance requirements. Despite these hurdles, innovations in functional capsule design and sustainable production methods are unlocking new opportunities in the sector.
Regionally, North America has historically dominated the empty capsules market, driven by a robust pharmaceutical industry and high healthcare expenditure. The presence of key players and a strong focus on research and development foster a favorable environment for market growth. Europe follows closely, with significant contributions from countries like Germany and France, underpinned by advancements in drug delivery technologies. Meanwhile, the Asia Pacific region is witnessing the fastest growth, buoyed by rising healthcare investments, increasing prevalence of lifestyle diseases, and expanding pharmaceutical manufacturing capabilities.
Major market players included in this report are:
By Type
Bovine
Bonemeal
Starch
By Functionality
North America
The expanding pharmaceutical and nutraceutical sectors, coupled with growing consumer inclination toward dietary supplements, are the primary catalysts for market growth. For instance, the surge in demand for plant-based alternatives has prompted the development of non-gelatin capsules such as Hydroxypropyl Methylcellulose (HPMC). Advances in capsule manufacturing technology enable precision customization for specific drug delivery needs, such as immediate-release or delayed-release formulations. However, the market faces challenges, including fluctuating raw material prices and stringent regulatory compliance requirements. Despite these hurdles, innovations in functional capsule design and sustainable production methods are unlocking new opportunities in the sector.
Regionally, North America has historically dominated the empty capsules market, driven by a robust pharmaceutical industry and high healthcare expenditure. The presence of key players and a strong focus on research and development foster a favorable environment for market growth. Europe follows closely, with significant contributions from countries like Germany and France, underpinned by advancements in drug delivery technologies. Meanwhile, the Asia Pacific region is witnessing the fastest growth, buoyed by rising healthcare investments, increasing prevalence of lifestyle diseases, and expanding pharmaceutical manufacturing capabilities.
Major market players included in this report are:
- Capsugel (Lonza Group)
- ACG Group
- Qualicaps Co., Ltd.
- Sunil Healthcare Ltd.
- CapsCanada Corporation
- Roxlor Group
- Shanxi Guangsheng Medicinal Capsules Co., Ltd.
- Snail Pharma Industry Co., Ltd.
- Associated Capsules Pvt. Ltd.
- HealthCaps India Ltd.
- Zhejiang Yuexi Capsule Co., Ltd.
- Suheung Co., Ltd.
- Fuji Capsule Co., Ltd.
- Ningbo Tianrun Capsule Co., Ltd.
- Medicaps Ltd.
By Type
- Gelatin
Bovine
Bonemeal
- Non-Gelatin
Starch
By Functionality
- Immediate-Release
- Sustained-Release
- Delayed-Release
- Antibiotic
- Dietary
- Antacid
- Cardiovascular Disease (CVD)
North America
- U.S.
- Canada
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Brazil
- Mexico
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Historical Year – 2022
- Base Year – 2024
- Forecast Period – 2024 to 2034
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional-level analysis for each market segment.
- Detailed analysis of geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand-side and supply-side analysis of the market
Table of Contents
285 Pages
- Chapter 1. Global Empty Capsules Market Executive Summary
- 1.1. Global Empty Capsules Market Size & Forecast (2024-2034)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Functionality
- 1.3.3. By Therapeutic Application
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Investment Analysis
- 1.7. Investment Rationale
- 1.8. Analyst Recommendation & Conclusion
- Chapter 2. Global Empty Capsules Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Empty Capsules Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Expansion of Pharmaceutical and Nutraceutical Sectors
- 3.1.2. Growing Consumer Inclination Toward Dietary Supplements
- 3.1.3. Advancements in Capsule Manufacturing Technology
- 3.2. Market Challenges
- 3.2.1. Fluctuating Raw Material Prices
- 3.2.2. Stringent Regulatory Compliance Requirements
- 3.3. Market Opportunities
- 3.3.1. Innovations in Functional Capsule Design
- 3.3.2. Sustainable Production Methods
- 3.3.3. Expansion into Emerging Markets
- Chapter 4. Global Empty Capsules Market Industry Analysis
- 4.1. Porter’s 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s 5 Force Model
- 4.1.7. Porter’s 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Empty Capsules Market Size & Forecasts by Type 2024-2034
- 5.1. Segment Dashboard
- 5.2. Global Empty Capsules Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Gelatin
- 5.2.2. Non-Gelatin
- Chapter 6. Global Empty Capsules Market Size & Forecasts by Functionality 2024-2034
- 6.1. Segment Dashboard
- 6.2. Global Empty Capsules Market: Functionality Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Immediate-Release
- 6.2.2. Sustained-Release
- 6.2.3. Delayed-Release
- Chapter 7. Global Empty Capsules Market Size & Forecasts by Therapeutic Application 2024-2034
- 7.1. Segment Dashboard
- 7.2. Global Empty Capsules Market: Therapeutic Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Antibiotic
- 7.2.2. Dietary
- 7.2.3. Antacid
- 7.2.4. Cardiovascular Disease (CVD)
- Chapter 8. Global Empty Capsules Market Size & Forecasts by Region 2024-2034
- 8.1. North America Empty Capsules Market
- 8.1.1. U.S. Empty Capsules Market
- 8.1.1.1. Type Breakdown Size & Forecasts, 2024-2034
- 8.1.1.2. Functionality Breakdown Size & Forecasts, 2024-2034
- 8.1.2. Canada Empty Capsules Market
- 8.2. Europe Empty Capsules Market
- 8.2.1. UK Empty Capsules Market
- 8.2.2. Germany Empty Capsules Market
- 8.2.3. France Empty Capsules Market
- 8.2.4. Spain Empty Capsules Market
- 8.2.5. Italy Empty Capsules Market
- 8.2.6. Rest of Europe Empty Capsules Market
- 8.3. Asia-Pacific Empty Capsules Market
- 8.3.1. China Empty Capsules Market
- 8.3.2. India Empty Capsules Market
- 8.3.3. Japan Empty Capsules Market
- 8.3.4. Australia Empty Capsules Market
- 8.3.5. South Korea Empty Capsules Market
- 8.3.6. Rest of Asia Pacific Empty Capsules Market
- 8.4. Latin America Empty Capsules Market
- 8.4.1. Brazil Empty Capsules Market
- 8.4.2. Mexico Empty Capsules Market
- 8.4.3. Rest of Latin America Empty Capsules Market
- 8.5. Middle East & Africa Empty Capsules Market
- 8.5.1. Saudi Arabia Empty Capsules Market
- 8.5.2. South Africa Empty Capsules Market
- 8.5.3. Rest of Middle East & Africa Empty Capsules Market
- Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Capsugel (Lonza Group)
- 9.1.2. ACG Group
- 9.1.3. Qualicaps Co., Ltd.
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Capsugel (Lonza Group)
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Market Strategies
- 9.3.2. Sunil Healthcare Ltd.
- 9.3.3. CapsCanada Corporation
- 9.3.4. Roxlor Group
- 9.3.5. Shanxi Guangsheng Medicinal Capsules Co., Ltd.
- 9.3.6. Snail Pharma Industry Co., Ltd.
- 9.3.7. Associated Capsules Pvt. Ltd.
- 9.3.8. HealthCaps India Ltd.
- 9.3.9. Zhejiang Yuexi Capsule Co., Ltd.
- 9.3.10. Suheung Co., Ltd.
- Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.